Company · CIK 2023658
Bicara Therapeutics Inc.
| CIK | 2023658 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | BCAX (Nasdaq) |
| First annual or quarterly report | 2024-11-12 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-290707 | 2025-10-03 | 2026-02-26 | 5 | |
| 333-281722 | 2024-08-22 | 2024-09-13 | 6 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-02-26 | 424B5Shelf takedown | 333-290707 | 0001193125-26-072875 |
| 2026-02-24 | 424B5Shelf takedown | 333-290707 | 0001193125-26-067160 |
| 2025-11-26 | EFFECTDeclared effective | 333-290707 | 9999999995-25-003395 |
| 2025-11-26 | 424B5Shelf takedown | 333-290707 | 0001193125-25-300510 |
| 2025-10-03 | S-3Shelf registered | 333-290707 | 0001193125-25-230307 |
| 2024-09-13 | 424B4Final prospectus | 333-281722 | 0001193125-24-218862 |
| 2024-09-12 | EFFECTDeclared effective | 333-281722 | 9999999995-24-002816 |
| 2024-09-11 | S-1/AAmendment | 333-281722 | 0001193125-24-217265 |
| 2024-09-06 | S-1/AAmendment | 333-281722 | 0001193125-24-214674 |
| 2024-09-03 | S-1/AAmendment | 333-281722 | 0001193125-24-211537 |
| 2024-08-22 | S-1Registration filed | 333-281722 | 0001193125-24-205393 |
| 2024-06-10 | DRSDraft made public | 377-07267 | 0000950123-24-006172 |